FDA NDC Directory · JSON-LD · Markdown

Skysona

NDC 73554-2111 · CELLULAR THERAPY · SUSPENSION

Generic nameelivaldogene autotemcel
Labeler / ManufacturerGenetix Biotherapeutics Inc.
Marketing categoryBiologic License Application · App BLA125755
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsELIVALDOGENE AUTOTEMCEL (30000000 1/1)
Marketing started20220916
Package count1

External sources

Source: openFDA. Public-domain (CC0).